Epithelial-to-mesenchymal transition in cancer: complexity and opportunities

The cell-biological program termed the epithelial-to-mesenchymal transition (EMT) plays an important role in both development and cancer progression. Depending on the contextual signals and intracellular gene circuits of a particular cell, this program can drive fully epithelial cells to enter into...

Full description

Bibliographic Details
Main Authors: Zhang, Yun, Weinberg, Robert A
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Language:English
Published: Higher Education Press 2018
Online Access:http://hdl.handle.net/1721.1/118855
https://orcid.org/0000-0002-0895-3557
_version_ 1811071104526057472
author Zhang, Yun
Weinberg, Robert A
author2 Massachusetts Institute of Technology. Department of Biology
author_facet Massachusetts Institute of Technology. Department of Biology
Zhang, Yun
Weinberg, Robert A
author_sort Zhang, Yun
collection MIT
description The cell-biological program termed the epithelial-to-mesenchymal transition (EMT) plays an important role in both development and cancer progression. Depending on the contextual signals and intracellular gene circuits of a particular cell, this program can drive fully epithelial cells to enter into a series of phenotypic states arrayed along the epithelial-mesenchymal phenotypic axis. These cell states display distinctive cellular characteristics, including stemness, invasiveness, drug-resistance and the ability to form metastases at distant organs, and thereby contribute to cancer metastasis and relapse. Currently we still lack a coherent overview of the molecular and biochemical mechanisms inducing cells to enter various states along the epithelial-mesenchymal phenotypic spectrum. An improved understanding of the dynamic and plastic nature of the EMT program has the potential to yield novel therapies targeting this cellular program that may aid in the management of high-grade malignancies. Keywords: epithelial-to-mesenchymal transition; cancer metastasis; cancer stem cell
first_indexed 2024-09-23T08:46:08Z
format Article
id mit-1721.1/118855
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T08:46:08Z
publishDate 2018
publisher Higher Education Press
record_format dspace
spelling mit-1721.1/1188552022-09-30T11:08:03Z Epithelial-to-mesenchymal transition in cancer: complexity and opportunities Zhang, Yun Weinberg, Robert A Massachusetts Institute of Technology. Department of Biology Ludwig Center for Molecular Oncology (Massachusetts Institute of Technology) Weinberg, Robert A The cell-biological program termed the epithelial-to-mesenchymal transition (EMT) plays an important role in both development and cancer progression. Depending on the contextual signals and intracellular gene circuits of a particular cell, this program can drive fully epithelial cells to enter into a series of phenotypic states arrayed along the epithelial-mesenchymal phenotypic axis. These cell states display distinctive cellular characteristics, including stemness, invasiveness, drug-resistance and the ability to form metastases at distant organs, and thereby contribute to cancer metastasis and relapse. Currently we still lack a coherent overview of the molecular and biochemical mechanisms inducing cells to enter various states along the epithelial-mesenchymal phenotypic spectrum. An improved understanding of the dynamic and plastic nature of the EMT program has the potential to yield novel therapies targeting this cellular program that may aid in the management of high-grade malignancies. Keywords: epithelial-to-mesenchymal transition; cancer metastasis; cancer stem cell National Institutes of Health (U.S.) (Grant R01- CA078461) 2018-11-02T19:25:26Z 2018-11-02T19:25:26Z 2018-07 2018-04 2018-10-25T05:12:15Z Article http://purl.org/eprint/type/JournalArticle 2095-0217 2095-0225 http://hdl.handle.net/1721.1/118855 Zhang, Yun and Robert A. Weinberg. “Epithelial-to-Mesenchymal Transition in Cancer: Complexity and Opportunities.” Frontiers of Medicine 12, 4 (July 2018): 361–373 © 2018 The Author(s) https://orcid.org/0000-0002-0895-3557 en https://doi.org/10.1007/s11684-018-0656-6 Frontiers of Medicine The Author(s) application/pdf Higher Education Press
spellingShingle Zhang, Yun
Weinberg, Robert A
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
title Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
title_full Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
title_fullStr Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
title_full_unstemmed Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
title_short Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
title_sort epithelial to mesenchymal transition in cancer complexity and opportunities
url http://hdl.handle.net/1721.1/118855
https://orcid.org/0000-0002-0895-3557
work_keys_str_mv AT zhangyun epithelialtomesenchymaltransitionincancercomplexityandopportunities
AT weinbergroberta epithelialtomesenchymaltransitionincancercomplexityandopportunities